Nitric Oxide (NO) can autoregulate its own formation by feedback inhibition of the inducible Nitric Oxide Synthase (INOS). Modulation of biosynthesis or activity of NO results in amelioration of pathogenesis of experimental arthritis. However, little is known about feedback mechanism on NO generation in response to adjuvant-induced arthritis. In the present study we have examined the effects of both prophylactic and therapeutic administration of isosorbide-5-mononitrate (5-IMN) on the development of adjuvant-induced arthritis to assess influence of high NO level in the form of exogenous NO donor in the progress of inflammation. Arthritis was assessed by measuring primary and secondary paw swelling and changes in thymus, spleen and body weight. Increased swelling of the non-injected paw (secondary paw) measured on days 14 and 21, injected paw swelling (primary paw) measured on days 3, 14 and 21, spleenomegaly, thymic involutions and loss in body wt. which are features of adjuvant induced arthritis were effectively reduced after prophylactic administration of 5-IMN (5.4 mg/kg, twice daily, p.o.). However, therapeutic administration of 5-IMN (5.4 mg/kg, twice daily, p.o.) from day 12 till day 16 had no effect on parameters measured in adjuvant-induced arthritis. These data suggest that high NO level in the form of NO donor compound may suppress initial stages of immune response to adjuvant injection probably by inhibiting iNOS expression through feedback inhibition mechanism. However, further studies are required to unravel the mechanism involved in these effects of NO donor and their clinical implications.